期刊文献+

抗精神病药致静坐不能的临床研究 被引量:5

A clinical study of akathisia caused by antipsychotics.
下载PDF
导出
摘要 目的 探讨抗精神病药 (APD)致静坐不能的临床特征及相关因素。方法 采用临床标准化评定工具对 2 60例精神分裂症住院病人进行 3个月的观察研究。结果 静坐不能发生率为 2 3 5 % ,不伴焦虑症状者为 3 6 1%。发生时间在治疗后 4周内及下午、晚上较多 (P <0 0 1) ;静坐不能组的APD治疗剂量、治疗前BPRS评分较高 (P <0 0 5或P <0 0 1) ;静坐不能评分与各临床变量无显著相关性。单发组与伴发组临床资料有一定差异 ;心得安治疗静坐不能效果良好 ,单发组疗效优于伴发组 (P <0 0 1) ,而对其他锥体外系症状疗效差。结论 静坐不能发生受生物时间、精神症状、药物及个体素质等因素的影响。静坐不能多数应归属于急性锥体外系反应 ,部分可能为药源性精神副反应的运动不宁状态。作者提出了静坐不能不同类别与处理措施。 Objective To explore the clinical features and the factors associate with akathisia caused by antipsychotics drug (APD).Methods A clinical observational study was carried out in 260 schizophrenc inpatients with the CCMD 2 R, the modified Sampson's extrapyramidal side effect rating scale, brief psychiatric rating scale (BPRS), Hamiton anxiety scale for three months.Results The incidence of akathisia was 23.5%, and of these 36.1% was not accompanied by anxiety. Akathisia happened four weeks after treatment, in the afternoon or in the evening ( P <0.01). The dosage of APD and BPRS score before treatment were higher in the akathisic group ( P <0.05 or P <0.01). There was no obvious relation between akathisia score and clinical features. The efficacy of propranolol for treating akathisia was better and its efficiency for treating other extrapramindal symtops was poor. Its effecacy in the akathisia only group was superior to that of the complicated group ( P <0.01).Conclusions The occurrence of akathisia was affected by biological time, psychiatric symptom, drug and personal diathesis. Most akathisia was due to the acute extrapramidal reaction arising from the use of drugs. The author moved the different categories and treating measnres of akathisia.
出处 《中国神经精神疾病杂志》 CAS CSCD 北大核心 2000年第2期81-83,共3页 Chinese Journal of Nervous and Mental Diseases
关键词 抗精神病药 静坐不能 药物不良作用 临床研究 Antipsychotic agents\ Akathisia\ Schizophrenia\ Clinical studies
  • 相关文献

参考文献6

  • 1童建明,国外医学.精神病学分册,1998年,25卷,1期,39页
  • 2汪广剑,国外医学.精神病学分册,1992年,19卷,1期,58页
  • 3王焕林,中华神经精神科杂志,1988年,21卷,5期,303页
  • 4沈渔--,精神医学(第2版),1988年,736页
  • 5缪晋英,国外医学.精神病学分册,1987年,14卷,2期,126页
  • 6郑瞻培,上海精神医学,1984年,3卷,1期,30页

同被引文献36

  • 1涂哲明,高申荣,叶仕能,解俊平,李道洋,邓雷,秦武辉,杨灿,潘峰,刘波.丁二酸洛沙平与盐酸氯丙嗪治疗精神分裂症的临床比较研究[J].中国民康医学,2004,16(7):415-416. 被引量:2
  • 2冯红梅.普萘洛尔(心得安)试验91例结果分析[J].临床和实验医学杂志,2006,5(11):1749-1749. 被引量:2
  • 3Bakaras P, Georgoussi M, Liakos A. Development of obsessive and depressive symptoms during rispexdone treatment. Br J Psychiatry, 1999, 174(6) :559.
  • 4Szechtman H, Culver K, Eilam D. Role d dopamine systems in obsessive -compulsive disorder(OCD):implications from a novel psychostimulant -induced animal model.Pol J Pharmacol, 1999,51 ( 1 ) :55.
  • 5Kurokawa K Nakamura K,Sumiyoshi T, et al. Venlaicular enlargement in schizophrenia spectrum patients with prodromal symptoms of obsessivecompulsive disorder.Psychiatry Res,2000,99(2):83.
  • 6Saxena S, Brody AL, Ho ML, et al. Cerebral metabolism in major depression and obsessive-compulsive disorder occurring separately and concurrently.Biol Psychiatry,2001,50(3) : 159.
  • 7De Hann L, Linszen DH , Gorsim R. Clozapine and obsessions in patient with recent -onset schizophrenia and other psychotic disorders.J Clin Psychiatry,1999,60(6) :364.
  • 8Tibbo P. Gendemann K. Improvement of obsessions and compulsions with clozapine in an individual with schizophrenia.Can J Psychiatry, 1999,44(10) : 1049.
  • 9Matsunaga H, Kiriike N, Matsui T, et al. Obsessive-compulsive disorder whit poor insight.Compr Psychiatry,2002,43( 2 ) : 150.
  • 10Pyurovsdy M, Fuchs C, Weizman A.Obsessive-compulssive disorder in patients with first-episode schizophrenia.Am J Psychiatry, 1999, 156(12) : 1998.

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部